163 related articles for article (PubMed ID: 11726648)
1. Interleukin (IL)-4 indirectly suppresses IL-2 production by human T lymphocytes via peroxisome proliferator-activated receptor gamma activated by macrophage-derived 12/15-lipoxygenase ligands.
Yang XY; Wang LH; Mihalic K; Xiao W; Chen T; Li P; Wahl LM; Farrar WL
J Biol Chem; 2002 Feb; 277(6):3973-8. PubMed ID: 11726648
[TBL] [Abstract][Full Text] [Related]
2. Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT.
Yang XY; Wang LH; Chen T; Hodge DR; Resau JH; DaSilva L; Farrar WL
J Biol Chem; 2000 Feb; 275(7):4541-4. PubMed ID: 10671476
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase.
Huang JT; Welch JS; Ricote M; Binder CJ; Willson TM; Kelly C; Witztum JL; Funk CD; Conrad D; Glass CK
Nature; 1999 Jul; 400(6742):378-82. PubMed ID: 10432118
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of interleukin-4 production in CD4+ T cells by peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: involvement of physical association between PPAR-gamma and the nuclear factor of activated T cells transcription factor.
Chung SW; Kang BY; Kim TS
Mol Pharmacol; 2003 Nov; 64(5):1169-79. PubMed ID: 14573767
[TBL] [Abstract][Full Text] [Related]
5. Regulation of macrophage gene expression by the peroxisome proliferator-activated receptor-gamma.
Ricote M; Welch JS; Glass CK
Horm Res; 2000; 54(5-6):275-80. PubMed ID: 11595817
[TBL] [Abstract][Full Text] [Related]
6. IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1.
Bendixen AC; Shevde NK; Dienger KM; Willson TM; Funk CD; Pike JW
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2443-8. PubMed ID: 11226258
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2.
Rockwell CE; Snider NT; Thompson JT; Vanden Heuvel JP; Kaminski NE
Mol Pharmacol; 2006 Jul; 70(1):101-11. PubMed ID: 16611855
[TBL] [Abstract][Full Text] [Related]
8. Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B.
Chung SW; Kang BY; Kim SH; Pak YK; Cho D; Trinchieri G; Kim TS
J Biol Chem; 2000 Oct; 275(42):32681-7. PubMed ID: 10934192
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the transcription factors AP-1 and NF-kappaB in CD4 T cells by peroxisome proliferator-activated receptor gamma ligands.
Wang P; Anderson PO; Chen S; Paulsson KM; Sjögren HO; Li S
Int Immunopharmacol; 2001 Apr; 1(4):803-12. PubMed ID: 11357893
[TBL] [Abstract][Full Text] [Related]
10. Lipoxygenase-derived metabolites are regulators of peroxisome proliferator-activated receptor gamma-2 expression in human vascular smooth muscle cells.
Limor R; Sharon O; Knoll E; Many A; Weisinger G; Stern N
Am J Hypertens; 2008 Feb; 21(2):219-23. PubMed ID: 18202670
[TBL] [Abstract][Full Text] [Related]
11. IL-4 induces apoptosis in A549 lung adenocarcinoma cells: evidence for the pivotal role of 15-hydroxyeicosatetraenoic acid binding to activated peroxisome proliferator-activated receptor gamma transcription factor.
Shankaranarayanan P; Nigam S
J Immunol; 2003 Jan; 170(2):887-94. PubMed ID: 12517954
[TBL] [Abstract][Full Text] [Related]
12. Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells.
Aoki Y; Kao PN
Antimicrob Agents Chemother; 1999 Nov; 43(11):2678-84. PubMed ID: 10543746
[TBL] [Abstract][Full Text] [Related]
13. Absence of T lymphocyte-derived cytokines fails to diminish macrophage 12/15-lipoxygenase expression in vivo.
Sendobry SM; Cornicelli JA; Welch K; Grusby MJ; Daugherty A
J Immunol; 1998 Aug; 161(3):1477-82. PubMed ID: 9686614
[TBL] [Abstract][Full Text] [Related]
14. Cellular and molecular mechanisms of the selective regulation of IL-12 production by 12/15-lipoxygenase.
Middleton MK; Rubinstein T; Puré E
J Immunol; 2006 Jan; 176(1):265-74. PubMed ID: 16365418
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells.
Gosset P; Charbonnier AS; Delerive P; Fontaine J; Staels B; Pestel J; Tonnel AB; Trottein F
Eur J Immunol; 2001 Oct; 31(10):2857-65. PubMed ID: 11592060
[TBL] [Abstract][Full Text] [Related]
16. A novel pathway involving progesterone receptor, 12/15-lipoxygenase-derived eicosanoids, and peroxisome proliferator-activated receptor gamma regulates implantation in mice.
Li Q; Cheon YP; Kannan A; Shanker S; Bagchi IC; Bagchi MK
J Biol Chem; 2004 Mar; 279(12):11570-81. PubMed ID: 14688261
[TBL] [Abstract][Full Text] [Related]
17. Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors.
Cunard R; Ricote M; DiCampli D; Archer DC; Kahn DA; Glass CK; Kelly CJ
J Immunol; 2002 Mar; 168(6):2795-802. PubMed ID: 11884448
[TBL] [Abstract][Full Text] [Related]
18. 15-lipoxygenase-1 metabolites down-regulate peroxisome proliferator-activated receptor gamma via the MAPK signaling pathway.
Hsi LC; Wilson L; Nixon J; Eling TE
J Biol Chem; 2001 Sep; 276(37):34545-52. PubMed ID: 11447213
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
Fahmi H; Di Battista JA; Pelletier JP; Mineau F; Ranger P; Martel-Pelletier J
Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774
[TBL] [Abstract][Full Text] [Related]
20. Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappa B p50.
Torgerson TR; Colosia AD; Donahue JP; Lin YZ; Hawiger J
J Immunol; 1998 Dec; 161(11):6084-92. PubMed ID: 9834092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
